EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · IEX Real-Time Price · USD
5.05
+0.08 (1.61%)
Jul 22, 2024, 10:00 AM EDT - Market open
EDAP TMS Employees
EDAP TMS had 307 employees as of December 31, 2023. The number of employees increased by 43 or 16.29% compared to the previous year.
Employees
307
Change (1Y)
43
Growth (1Y)
16.29%
Revenue / Employee
$214,332
Profits / Employee
-$64,555
Market Cap
184.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Coherus BioSciences | 306 |
Generation Bio Co. | 174 |
Inhibrx | 172 |
ClearPoint Neuro | 107 |
G1 Therapeutics | 100 |
Fractyl Health | 94 |
Lineage Cell Therapeutics | 75 |
Trevi Therapeutics | 25 |
EDAP News
- 2 days ago - EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis - GlobeNewsWire
- 7 weeks ago - EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations - GlobeNewsWire
- 2 months ago - EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 2 months ago - EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024 - GlobeNewsWire
- 3 months ago - EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 4 months ago - EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024 - GlobeNewsWire
- 4 months ago - EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 5 months ago - EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis - GlobeNewsWire